TOP STORIES

• BUSINESS Regeneron Lines Up 5 Late-Stage Assets for Japan: Commercial Head
  December 11, 2025

• BUSINESS Asahi Kasei Pharma Confident of Hitting FY2030 Group Sales Target: President
  December 10, 2025

• BUSINESS LinqMed Builds Radiopharma Plant in Rare Manufacturing Bet for Biotech Startup
  December 9, 2025

• REGULATORY PMDA to Adopt General-Purpose AI in FY2025, Eyes Specialized Tools for Reviews and Safety Work
  December 8, 2025

• REGULATORY Japan Likely to Extend Generic-Name Prescribing Premium to Biologics to Spur Biosimilars
  December 8, 2025

• REGULATORY R&D Tax Credit Draws Broad Calls for Maintenance, Expansion: LDP Meeting
  December 8, 2025

• REGULATORY Forxiga, Zytiga Seen Taking Biggest Hit by PMP Returns in FY2026
  December 5, 2025

• REGULATORY FY2026 Reform Roadmap Keeps Key Drug Pricing Issues on Ice, Snubs Many Industry Requests: Chuikyo
  December 4, 2025

• REGULATORY Average NHI-Market Price Gap Hits Fresh Record Low at 4.8%
  December 3, 2025

• REGULATORY MOF Panel Submits Budget Proposal, Urges Wider CEA Use and More Frequent Re-Pricing
  December 3, 2025

• BUSINESS Lundbeck Japan Plans to Double Workforce by 2028 as It Eyes 3 Drug Approvals
  December 2, 2025

• REGULATORY Japan Allocates 100 Billion-Plus Yen for Drug Innovation, Generic Funds: FY2025 Extra Budget
  December 1, 2025

• BUSINESS Insmed Japan to Double Sales Force with Brensocatib Launch on the Horizon
  November 28, 2025

• REGULATORY US Unveils Up to 85% Price Cuts for IRA Round-2; Astellas’ Xtandi on the List
  November 27, 2025

• BUSINESS Novartis Eyes Broader Radioligand Therapy Footprint in Japan as Pluvicto Debuts
  November 26, 2025

• BUSINESS Eisai to Unify Global HR Framework by 2029 to Bolster Leqembi Growth
  November 25, 2025

• BUSINESS Marubeni Pharma Targets Doubling Profits by FY2035 with 2 New Deals Each Year
  November 25, 2025

• REGULATORY LDP, Ishin Start Framing Copay Models for OTC-Like Drugs: Bilateral Talks
  November 25, 2025

• REGULATORY Japan Finalizes Economic Package Positioning Pharma as “Core Industry”
  November 25, 2025

• REGULATORY Patient Groups Push Back against Delisting OTC-Like Drugs; Panel Leans Toward Higher Copays
  November 21, 2025

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »